Literature DB >> 2067610

Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study.

C W Shepherd1, B W Scheithauer, M R Gomez, H J Altermatt, J A Katzmann.   

Abstract

Of 345 patients with tuberous sclerosis complex evaluated at the Mayo Clinic from 1950 to 1989, 23 were identified as having brain tumors. In 20 of the 23, histological or clinical evidence showed the tumor to be a subependymal giant cell astrocytoma. A search of the Mayo Clinic tissue registry yielded 73 giant cell-containing astrocytomas and intraventricular gliomas exclusive of ependymomas. Reexamination revealed no further examples of subependymal giant cell astrocytoma in patients without features of the tuberous sclerosis complex. Considerable histological variation was observed in the 15 subependymal giant cell astrocytomas subjected to critical microscopic review. It is of note that no correlation was noted between either the histological features, such as atypia, mitoses, endothelial proliferations, necrosis, or the flow cytometric characteristics and the clinical course or the survival time of the patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2067610

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  26 in total

1.  Subependymal giant cell astrocytoma--a clinicopathological study of 23 cases with special emphasis on histogenesis.

Authors:  Mehar Chand Sharma; Angela Mercy Ralte; Shailesh Gaekwad; Vani Santosh; S K Shankar; Chitra Sarkar
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

Review 2.  Neurological manifestations of tuberous sclerosis complex.

Authors:  P Curatolo
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

3.  The clinical characteristics of subependymal giant cell astrocytoma: five cases.

Authors:  Tae-Young Jung; Young-Hee Kim; Shin Jung; Hee-Jo Baek; Kyung-Hwa Lee
Journal:  Brain Tumor Res Treat       Date:  2015-04-29

4.  Intraventricular glioneuronal hamartoma: histopathological correlation with magnetic resonance spectroscopy.

Authors:  Manish S Sharma; Ashish Suri; Tariq Shah; Angela Ralte; Chitra Sarkar; Vipul Gupta; Veer S Mehta
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

5.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.

Authors:  H Onda; A Lueck; P W Marks; H B Warren; D J Kwiatkowski
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex.

Authors:  Jerry A Shields; Ralph C Eagle; Carol L Shields; Brian P Marr
Journal:  Trans Am Ophthalmol Soc       Date:  2004

7.  Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.

Authors:  Àlex Rovira; María Luz Ruiz-Falcó; Elena García-Esparza; Eduardo López-Laso; Alfons Macaya; Ignacio Málaga; Élida Vázquez; Josefina Vicente
Journal:  J Neurooncol       Date:  2014-04-27       Impact factor: 4.130

8.  Longitudinal CT and MR appearances of hemimegalencephaly in a patient with tuberous sclerosis.

Authors:  Ravikanth Balaji; Chandrasekharan Kesavadas; K Ramachandran; S Dinesh Nayak; T Priyakumari
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

9.  Subependymal giant-cell astrocytoma associated with tuberous sclerosis: case report.

Authors:  R Ergün; A I Okten; M Yaman; A R Gezici; Y Taşkin
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 10.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.